PC
GILD icon

Pier Capital’s Gilead Sciences GILD Stock Holding History

Pier Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-595
Closed -$63K – 123
2014
Q3 		$63K Sell
595
-25
-4% -$2.45K 0.01% 123
2014
Q2 		$51K Sell
620
-954
-61% -$74.3K 0.01% 132
2014
Q1 		$112K Hold
1,574
– – 0.01% 112
2013
Q4 		$118K Hold
1,574
– – 0.02% 107
2013
Q3 		$99K Hold
1,574
– – 0.01% 111
2013
Q2 		$81K Buy
+1,574
New +$82K 0.01% 109

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pier Capital's GILD Position: Q4 2014 in Review

Pier Capital sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 595 shares — an estimated $63K sold.

Pier Capital first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $118K in Q4 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Pier Capital reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Pier Capital sold 595 Gilead Sciences shares in Q4 2014, an estimated $63K.
  • Pier Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Pier Capital's Gilead Sciences position peaked at $118K in Q4 2013.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Pier Capital's 13F filing for Q4 2014, filed 10 Feb 2015.